Tag

Human Clinical Trials

All articles tagged with #human clinical trials

science-and-technology2 years ago

"Groundbreaking Discovery: Chemical Cocktails Reverse Aging!"

Scientists from Harvard and MIT have discovered six chemical compounds that can reverse key signs of aging in cells. The "chemical cocktails" were found to restore youthful properties to cells within four days of treatment. Unlike risky gene therapies, these chemicals act via epigenetics, controlling gene expression without altering DNA sequences. Preparations are underway for human clinical trials of "age reversal gene therapy." The findings have attracted interest from tech billionaires investing in longevity research, with the potential to extend human lifespans and improve health in old age.

health2 years ago

"Harvard Scientists Unveil Age-Reversing Pill: The Fountain of Youth Found?"

Harvard researchers claim to have discovered a chemical cocktail that can reverse aging, potentially leading to the development of a "Fountain of Youth" pill. The cocktails, containing five to seven agents, include prescription medications used to treat seizures, depression, and Parkinson's. Through experiments on mice and monkeys, the researchers identified six cocktails that can reverse visual signs of aging in less than a week. Human clinical trials are being prepared, with other researchers also exploring the rejuvenating effects of chemicals.

health2 years ago

Boosting Brain Power: Hormone Injection Reverses Age-Related Memory Decline in Monkeys

A study published in Nature Aging has found that a single injection of the klotho protein led to modest improvements in cognitive function in older monkeys, with effects lasting for two weeks. Klotho, a protein produced by the kidney, has been linked to health and lifespan. Previous studies have shown that higher levels of klotho are associated with better cognitive performance in humans and mice. The researchers believe that klotho represents a promising avenue for researching the rejuvenation of brain function in older adults and are planning to test lower doses in human clinical trials.